Literature DB >> 15467404

Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP).

Kazuhide Uemura1, Harumi Yamamoto, Tomoaki Nakagawa, Kishiko Nakamura, Nobuko Kawasaki, Shogo Oka, Bruce Yong Ma, Toshisuke Kawasaki.   

Abstract

Mannan-binding protein (MBP) is a Ca(2+)-dependent mammalian lectin that plays an important role in innate immunity. In this study, we found that ligand-bound MBP stimulates polymorphonuclear leukocytes (PMN) to induce cell aggregation and superoxide production. The biological response of PMN to ligand-bound MBP was dose- and time-dependent. The PMN aggregation and superoxide production induced by ligand-bound MBP was blocked completely by pertussis toxin, and partially blocked by a platelet activation factor receptor antagonist, TCV-309. These findings suggest that the ligand-bound MBP stimulates PMN through a putative MBP receptor(s) on PMN.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15467404     DOI: 10.1023/B:GLYC.0000043753.11090.88

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  24 in total

Review 1.  Structure and biology of mannan-binding protein, MBP, an important component of innate immunity.

Authors:  T Kawasaki
Journal:  Biochim Biophys Acta       Date:  1999-12-06

2.  Direct killing of interleukin-2-transfected tumor cells by human neutrophils.

Authors:  F Pericle; R A Kirken; P K Epling-Burnette; D K Blanchard; J Y Djeu
Journal:  Int J Cancer       Date:  1996-05-03       Impact factor: 7.396

3.  Oligomeric structures required for complement activation of serum mannan-binding proteins.

Authors:  Y Yokota; T Arai; T Kawasaki
Journal:  J Biochem       Date:  1995-02       Impact factor: 3.387

4.  Functional expression of human mannan-binding proteins (MBPs) in human hepatoma cell lines infected by recombinant vaccinia virus: post-translational modification, molecular assembly, and differentiation of serum and liver MBP.

Authors:  Y Ma; H Shida; T Kawasaki
Journal:  J Biochem       Date:  1997-10       Impact factor: 3.387

5.  Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin.

Authors:  H Kurata; H M Cheng; Y Kozutsumi; Y Yokota; T Kawasaki
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

Review 6.  Carbohydrate-mediated recognition systems in innate immunity.

Authors:  T Feizi
Journal:  Immunol Rev       Date:  2000-02       Impact factor: 12.988

7.  Interplay between promoter and structural gene variants control basal serum level of mannan-binding protein.

Authors:  H O Madsen; P Garred; S Thiel; J A Kurtzhals; L U Lamm; L P Ryder; A Svejgaard
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

8.  Complement receptor 1/CD35 is a receptor for mannan-binding lectin.

Authors:  I Ghiran; S F Barbashov; L B Klickstein; S W Tas; J C Jensenius; A Nicholson-Weller
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

9.  The human mannose-binding protein functions as an opsonin.

Authors:  M Kuhlman; K Joiner; R A Ezekowitz
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Human leukocyte C1q receptor binds other soluble proteins with collagen domains.

Authors:  R Malhotra; S Thiel; K B Reid; R B Sim
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

View more
  2 in total

1.  Mannose-binding lectin deficiency influences innate and antigen-presenting functions of blood myeloid dendritic cells.

Authors:  Melinda M Dean; Robert L Flower; Damon P Eisen; Robyn M Minchinton; Derek N J Hart; Slavica Vuckovic
Journal:  Immunology       Date:  2010-11-23       Impact factor: 7.397

2.  The effect of conglutinin on production of reactive oxygen species in bovine granulocytes.

Authors:  Marta Dec; Andrzej Wernicki; Andrzej Puchalski; Renata Urban-Chmiel; Adam Waśko
Journal:  J Vet Sci       Date:  2012-03       Impact factor: 1.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.